AIM Vaccine Co., Ltd. — Investor Relations & Filings
AIM Vaccine Co., Ltd. is a biopharmaceutical company focused on the research, development, manufacturing, and commercialization of vaccines for human use. The company's mission is to produce high-quality vaccines to safeguard global health. It holds a leading position among privately-owned vaccine enterprises in its primary market. The core product portfolio includes established vaccines such as Recombinant Hepatitis B Vaccine (Hansenula polymorpha), Inactivated Hepatitis A Vaccine (Human Diploid Cell), and Meningococcal Polysaccharide Vaccine. AIM Vaccine is also a major global supplier of rabies vaccines, committed to leading technological advancements in this area. The company actively expands its pipeline, which features advanced candidates like the 13-valent pneumonia conjugate vaccine and iterative serum-free rabies vaccine, alongside strategic investments in mRNA technology, including an mRNA COVID-19 vaccine candidate.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| List of Directors and Their Roles and Functions | 2022-10-05 | English | |
| Terms of Reference of the Nomination Committee of the Board of Directors | 2022-10-05 | English | |
| Terms of Reference of the Remuneration and Appraisal Committee of the Board of Directors | 2022-10-05 | English | |
| Terms of Reference of the Audit Committee of the Board of Directors | 2022-10-05 | English | |
| Articles of Association | 2022-10-05 | English | |
| Announcement of Allotment Results | 2022-10-05 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2022
14 filings
| |||||
| 32567928 | List of Directors and Their Roles and Functions | 2022-10-05 | English | ||
| 32567929 | Terms of Reference of the Nomination Committee of the Board of Directors | 2022-10-05 | English | ||
| 32567930 | Terms of Reference of the Remuneration and Appraisal Committee of the Board of Directors | 2022-10-05 | English | ||
| 32567931 | Terms of Reference of the Audit Committee of the Board of Directors | 2022-10-05 | English | ||
| 32567932 | Articles of Association | 2022-10-05 | English | ||
| 32567933 | Announcement of Allotment Results | 2022-10-05 | English | ||
| 32567934 | Documents on Display | 2022-09-23 | English | ||
| 32567935 | GREEN APPLICATION FORM | 2022-09-23 | English | ||
| 32567936 | GLOBAL OFFERING | 2022-09-23 | English | ||
| 32567937 | GLOBAL OFFERING | 2022-09-23 | English | ||
| 32567939 | PHIP (1st submission) | 2022-09-19 | English | ||
| 32567938 | PHIP (1st submission) | 2022-09-19 | English | ||
| 32567941 | Application Proof (1st submission) | 2022-04-08 | English | ||
| 32567940 | Application Proof (1st submission) | 2022-04-08 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
AIM Vaccine Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/51022/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=51022 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=51022 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=51022 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 51022}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for AIM Vaccine Co., Ltd. (id: 51022)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.